Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 136941, 8 pages
http://dx.doi.org/10.1155/2015/136941
Research Article

MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric Cancer

1Department of Surgical Oncology, The Fourth Hospital of Harbin Medical University, Harbin 150010, China
2Central Laboratory, School of Stomatology, Peking University, Beijing 100081, China
3Department of Nephrology, First Affiliated Hospital of Harbin Medical University, Harbin 150010, China

Received 21 April 2014; Revised 10 October 2014; Accepted 6 November 2014

Academic Editor: Haiteng Deng

Copyright © 2015 Changlu Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. L. Chen, X. Z. Chen, C. Yang et al., “Docetaxel, Cisplatin and Fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 4, Article ID e60320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. H. Hartgrink, E. P. Jansen, N. C. van Grieken, and C. J. van de Velde, “Gastric cancer,” The Lancet, vol. 374, no. 9688, pp. 477–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” Ca: Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Songun, H. Putter, E. M. K. Kranenbarg, M. Sasako, and C. J. van de Velde, “Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial,” The Lancet Oncology, vol. 11, no. 5, pp. 439–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Mariotto, K. Robin Yabroff, Y. Shao, E. J. Feuer, and M. L. Brown, “Projections of the cost of cancer care in the United States: 2010–2020,” Journal of the National Cancer Institute, vol. 103, no. 2, pp. 117–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Pan, M. He, J. Ma et al., “Phase and size controllable synthesis of NaYbF4 nanocrystals in oleic acid/ ionic liquid two-phase system for targeted fluorescent imaging of gastric cancer,” Theranostics, vol. 3, no. 3, pp. 210–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. Jones and S. B. Baylin, “The Epigenomics of Cancer,” Cell, vol. 128, no. 4, pp. 683–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Vogiatzi, C. Vindigni, F. Roviello, A. Renieri, and A. Giordano, “Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis,” Journal of Cellular Physiology, vol. 211, no. 2, pp. 287–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Song, S. W. Han, and Y. J. Bang, “Epigenetic-Based therapies in cancer: progress to date,” Drugs, vol. 71, no. 18, pp. 2391–2403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B.-G. Jang and W. H. Kim, “Molecular pathology of gastric carcinoma,” Pathobiology, vol. 78, no. 6, pp. 302–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Tsuchiya, G. Tamura, K. Sato et al., “Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia,” Oncogene, vol. 19, no. 32, pp. 3642–3646, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Fleisher, M. Esteller, G. Tamura et al., “Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia,” Oncogene, vol. 20, no. 3, pp. 329–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Q.-L. Li, K. Ito, C. Sakakura et al., “Causal relationship between the loss of RUNX3 expression and gastric cancer,” Cell, vol. 109, no. 1, pp. 113–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Wanajo, A. Sasaki, H. Nagasaki et al., “Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer,” Gastroenterology, vol. 135, no. 2, pp. 580–e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Yu, Q. Tao, Y. Y. Cheng et al., “Promoter methylation of the Wnt/β-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer,” Cancer, vol. 115, no. 1, pp. 49–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Chen, X. Cao, W. Dong et al., “Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 1070–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Zhao, Q. Li, J. Wang et al., “Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal Cancer,” PLoS ONE, vol. 7, no. 11, Article ID e49683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. F. Peng, T. L. Hu, B. G. Schneider, Z. Chen, Z. K. Xu, and W. El-Rifai, “Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas,” PLoS ONE, vol. 7, no. 10, Article ID e46214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Mazzolini, P. Rodrigues, S. Bazzocco et al., “Brush border myosin Ia inactivation in gastric but not endometrial tumors,” International Journal of Cancer, vol. 132, no. 8, pp. 1790–1799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. K. Watanabe, T. Katagiri, M. Suzuki et al., “Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats,” Genomics, vol. 38, no. 3, pp. 273–276, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Mori, K. Cai, Y. Cheng et al., “A genome-wide search identifies epigenetic silencing of somatostatin , tachykinin-1, and 5 other genes in colon cancer,” Gastroenterology, vol. 131, no. 3, pp. 797–808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Jin, Y. Mori, J. Yang et al., “Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma,” Oncogene, vol. 26, no. 43, pp. 6332–6340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ehrich, M. R. Nelson, P. Stanssens et al., “Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 44, pp. 15785–15790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Stanssens, M. Zabeau, G. Meersseman et al., “High-throughput MALDI-TOF discovery of genomic sequence polymorphisms,” Genome Research, vol. 14, no. 1, pp. 126–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ehrich, J. Turner, P. Gibbs et al., “Cytosine methylation profiling of cancer cell lines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 12, pp. 4844–4849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Hudler, “Genetic aspects of gastric cancer instability,” The Scientific World Journal, vol. 2012, Article ID 761909, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Klose and A. P. Bird, “Genomic DNA methylation: the mark and its mediators,” Trends in Biochemical Sciences, vol. 31, no. 2, pp. 89–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Bellido, R. Radpour, O. Lapaire et al., “MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma,” Biology of Reproduction, vol. 82, no. 4, pp. 745–750, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Herman and S. B. Baylin, “Gene silencing in cancer in association with promoter hypermethylation,” The New England Journal of Medicine, vol. 349, no. 21, pp. 2042–2054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Zou, J. Shen, F. Chen et al., “NELL-1 binds to APR3 affecting human osteoblast proliferation and differentiation,” FEBS Letters, vol. 585, no. 15, pp. 2410–2418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Ting, H. Vastardis, J. B. Mulliken et al., “Human NELL-1 expressed in unilateral coronal synostosis,” Journal of Bone and Mineral Research, vol. 14, no. 1, pp. 80–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Rocco, D. Compare, and G. Nardone, “Cancer stem cell hypothesis and gastric carcinogenesis: experimental evidence and unsolved questions,” World Journal of Gastrointestinal Oncology, vol. 4, pp. 54–59, 2012. View at Google Scholar
  34. Y. Mori, K. Cai, Y. Cheng et al., “A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer,” Gastroenterology, vol. 131, no. 3, pp. 797–808, 2006. View at Publisher · View at Google Scholar · View at Scopus